Omar Nadeem, Md

This study tests a combination of three drugs (ixazomib, pomalidomide, and dexamethasone) given twice a week to people with multiple myeloma that has come back or stopped responding to treatment. The goal is to see if this combination can control the cancer and how safe it is. Ab…